These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24845944)

  • 1. Efficacy of antidepressant medications in children and adolescents with non-obsessive-compulsive disorder anxiety disorders: a systematic assessment.
    Gentile S
    Expert Opin Drug Saf; 2014 Jun; 13(6):735-44. PubMed ID: 24845944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
    Donovan MR; Glue P; Kolluri S; Emir B
    J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New indications for antidepressants.
    Schatzberg AF
    J Clin Psychiatry; 2000; 61 Suppl 11():9-17. PubMed ID: 10926050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment of anxiety disorders.
    Mavissakalian M
    J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of childhood anxiety disorders: what is the place for antidepressants?
    Muris P
    Expert Opin Pharmacother; 2012 Jan; 13(1):43-64. PubMed ID: 22149367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current knowledge of medications for the treatment of childhood anxiety disorders.
    Allen AJ; Leonard H; Swedo SE
    J Am Acad Child Adolesc Psychiatry; 1995 Aug; 34(8):976-86. PubMed ID: 7665455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of antidepressant medications in children and adolescents with obsessive-compulsive disorder: a systematic appraisal.
    Gentile S
    J Clin Psychopharmacol; 2011 Oct; 31(5):625-32. PubMed ID: 21869690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: A meta-analysis.
    Sugarman MA; Kirsch I; Huppert JD
    J Affect Disord; 2017 Aug; 218():217-226. PubMed ID: 28477500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN; Stein MB
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in the use of antidepressant and anxiolytic medications.
    Simeon JG; Ferguson HB
    Psychiatr Clin North Am; 1985 Dec; 8(4):893-907. PubMed ID: 2867535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nontricyclic antidepressants: current trends in children and adolescents.
    Emslie GJ; Walkup JT; Pliszka SR; Ernst M
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):517-28. PubMed ID: 10230183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of generalized anxiety disorder.
    Davidson JR
    J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychopharmacology of social phobia and comorbid disorders.
    Rosenbaum JF; Pollock RA
    Bull Menninger Clin; 1994; 58(2 Suppl A):A67-83. PubMed ID: 7913851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New uses for antidepressants: social phobia.
    Keck PE; McElroy SL
    J Clin Psychiatry; 1997; 58 Suppl 14():32-6; discussion 37-8. PubMed ID: 9418744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of comorbid anxiety and depression.
    Zajecka JM; Ross JS
    J Clin Psychiatry; 1995; 56 Suppl 2():10-3. PubMed ID: 7844101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar disorder and comorbid anxiety disorders in children and adolescents.
    Dineen Wagner K
    J Clin Psychiatry; 2006; 67 Suppl 1():16-20. PubMed ID: 16426112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and risks of using antidepressants in children and adolescents.
    Bailly D
    Expert Opin Drug Saf; 2008 Jan; 7(1):9-27. PubMed ID: 18171311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacologic treatment of anxiety disorders in adolescents and children.
    Popper CW
    J Clin Psychiatry; 1993 May; 54 Suppl():52-63. PubMed ID: 8099578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current drug treatment. Effects of antidepressive agents in nervous and stress-related disorders].
    Rosenberg R
    Ugeskr Laeger; 2001 Apr; 163(14):1985-91. PubMed ID: 11307357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.